MARK ARDOIN: Open Payments
NPI 1114454659 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 5 payments from 4 companies in 2025. Trend: 2023 $51 · 2024 $68 · 2025 $307
Food & beverage: $207Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $150 |
| Teva Pharmaceuticals USA, Inc. | 2 | $121 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: LUMIGAN, UZEDY, INGREZZA, COBENFY.
Industry payments across LA — which companies pay providers there.
